"Demanson" lipolytic enzyme correction reagent - Taiwan Registration 9622ecab906e025412b858e9bee8fd4b

Access comprehensive regulatory information for "Demanson" lipolytic enzyme correction reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9622ecab906e025412b858e9bee8fd4b and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.